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Oesophageal atresia and tracheoesophageal fistula (OA–TOF) are a multifaceted con-
dition which affects patients throughout their lives. Even though it is one of the most 
common gastrointestinal malformations, most of the current studies focus on gastro-oe-
sophageal reflux disease, anastomotic strictures, and feeding difficulties. However, there 
is increasing evidence that a proportion of patients with OA–TOF also have abnormal 
gastric function. This review aims to provide a comprehensive understanding of studies 
of gastric function in patients with OA–TOF. The etiology of this abnormality has been 
hypothesized to be congenital and/or acquired. Several modalities are currently available 
for the investigation of gastric function, each of them trying to answer specific clinical 
questions. This review summarizes the studies that have looked at gastric function in 
the OA–TOF cohort with gastric emptying studies (gastric emptying scintigraphy and 
13C octanoic breath test), gastric manometry, electrogastrography, and oral glucose 
tolerance test. However, these modalities are limited due to poor age-specific normative 
values and heterogeneous methodologies used. The evaluation of symptoms in this 
cohort is crucial, modalities for abnormal gastric function are also described. With 
appropriate investigations and symptoms questionnaires, treatment strategies can be 
implemented to correct abnormal gastric function and thereby improve the outcomes 
and quality of life of patients with OA–TOF. This review highlights the need for large 
international multicentre collaborative studies and high-quality prospective randomized 
controlled trials to improve our understanding of gastric function in this cohort.
Keywords: oesophageal atresia/tracheo-oesophageal fistula, children and adolescents, gastric motility, gastric 
emptying, electrogastrography, octanoic breath test, dumping syndrome, prokinetic
iNTRODUCTiON
Oesophageal atresia (OA) and tracheoesophageal fistula (TOF) are defined as an interruption 
of the continuity of the oesophageal lumen, which can be associated with or without the pres-
ence of a TOF. The abnormal communication can occur between the proximal and/or the distal 
oesophagus and the trachea. OA–TOF is known to be one of the most common malformations in 
the gastrointestinal tract. Regarding its incidence, OA–TOF has been reported in approximately 
1 in 3,500 births (1).
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Recently, there have been significant improvements in the 
care of patients with OA–TOF with the involvement of mul-
tidisciplinary teams including the surgeon, gastroenterologist, 
otorhinolaryngologist, pulmonologist, nutritionist, speech 
pathologist, and psychologist. This team approach to the care 
along with improvements in the initial neonatal management 
(intensive care, anesthesia, ventilatory, and nutritional support) 
in association with the primary surgical repair, has resulted in 
a significant reduction of the mortality with a current survival 
rate as high as 95% in centers with the best neonatal care (2). 
Most of the patients who do not survive the first months of 
life often have severe concomitant malformations. Despite this 
reduction in the mortality rate, children with OA–TOF can 
demonstrate a significant amount of long-term complications 
and suffer from lifelong morbidity due to complications, such as 
gastroesophageal reflux disease (GORD), oesophageal dysmo-
tility, Barretts oesophagus, anastomotic strictures, and feeding 
difficulties.
The aim of the recent consensus guidelines on the manage-
ment of gastrointestinal complications in these patients by 
NASPGHAN and ESPGHAN was to improve patient-related 
outcomes and the quality of life of patients by reducing the 
morbidity from gastrointestinal complications in this cohort (3).
While much is known about the abnormal oesophageal 
function and poor motility in OA–TOF patients (4, 5), little 
is known about gastric function in OA–TOF patients. It has 
been postulated that abnormalities in gastric function may 
contribute to high prevalence of gastrointestinal complica-
tions, such as GORD and feeding difficulties in this cohort. 
This review will discuss the etiology of abnormal gastric 
function, investigations of gastric function, symptoms that 
could be secondary to abnormal gastric functions, and finally 
potential treatment strategies for abnormal gastric function 
in this cohort.
PATHOPHYSiOLOGY
The normal gastric motor function is a complex sequence of 
events. All of them are controlled by an extrinsic nerve supply 
(brain and spinal cord), myenteric plexus within the wall of the 
stomach, and the result of local transmitters (amines and pep-
tides), that modulate the excitability of the smooth muscle of the 
stomach.
Autonomic Nervous System
The parasympathetic pathway is transmitted to the stomach via 
the vagus nerves. Qi et al. (6) have described congenital abnor-
malities in the course and branching of the vagus nerves in a rat 
model with OA–TOF. The left vagus nerve consistently followed 
an abnormal path below the aortic arch, which could potentially 
increase the risk of damage to the vagus at time of initial repair 
of the OA–TOF. It has also been postulated that complications, 
such as postoperative infections, anastomotic strictures, leaks, 
and tension and ischemia at anastomotic site, could have a further 
adverse effect on the integrity of the vagi and thereby affect gastric 
function.
enteric Nervous System
Focusing on the enteric nervous system, Nakazato et  al. (7) 
documented an abnormal development of the myenteric plexus 
(Auerbach plexus) in the oesophagus as well as in the stomach 
in a small series of five patients. Most of the gastric biopsy speci-
mens of patients showed significantly larger ganglia and thicker 
inter-ganglionic fibers than normal, and the network was also 
looser than normal. Interestingly, in an animal OA–TOF model, 
anomalies of the myenteric plexus of the oesophagus in OA–TOF 
rats were also reported by Qi et al. (8). They describe a reduction 
of the number of cell bodies within the ganglia and a decrease of 
the density of ganglia and nerve fibers. These abnormalities in 
the enteric nervous system could also have an adverse effect on 
gastric function.
Gastric Smooth Muscles
There are a paucity of studies investigating the role of the gastric 
smooth muscles contractility. Tugay et al. (9) reported physiologic 
changes of the smooth muscle of stomach in rat fetuses with OA–
TOF in comparison with controls. This was investigated via both 
receptor-dependent (carbachol, serotonin, isoproterenol) and 
receptor-independent agonist (KCl, papaverine) mechanisms. 
The results showed an inadequate gastric muscular contraction 
in both mechanisms. However, this was an in vitro animal study 
which limits its extrapolation to in vivo gastric function.
In summary, there is limited evidence that congenital and 
acquired abnormalities of the autonomic nervous system (extrin-
sic), enteric nervous system (intrinsic), and potentially even the 
gastric smooth muscle could result in abnormal gastric function 
in OA–TOF patients. However, as a lot this evidence was either 
from animal studies or small case series, further corroboration 
needs to be done in larger cohorts’ studies on patients with 
OA–TOF.
CLiNiCAL SYMPTOMS OF ABNORMAL 
GASTRiC FUNCTiON
Most of the questionnaires currently available, such as the 
gastroparesis cardinal symptom index, which is itself a subset 
of the PAGI-SYM (patient assessment of upper gastrointestinal 
disorders-symptoms) are not validated in a pediatric population 
(10–12). No questionnaire exists for a proxy-report. To assess 
gastrointestinal symptoms in children, the Rome Foundation 
establishes questionnaires especially for gastrointestinal func-
tional disorders (13). The PedsQL Gastrointestinal Symptoms 
Module was established and validated to use several scales to 
report the quality of life of children, such as symptoms scale, 
worry scale, medication scale, and communication scale (14). It 
can assess functional gastrointestinal disease or organic disease 
(15). The PedsQL currently has subsections which relate to gastric 
dysfunction. Questions on stomach pain and discomfort after 
eating, limitation of the child’s ability to eat certain foods, early 
satiety, nausea, vomiting, sensation of “bloating,” and abdominal 
distension, all give information on the presence of gastric dys-
function in the PedsQL. However, the difficulty in gastric dys-
function is that the symptoms are non-specific, and especially in 
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an OA–TOF patients, in whom GORD, eosinophilic oesophagitis, 
and oesophageal dysmotility may result in similar symptoms.
iNveSTiGATiONS OF GASTRiC FUNCTiON
Diagnosing abnormal gastric function in children, including 
those with OA–TOF, is challenging as several modalities are 
available, and each of them may provide a different physiologic 
answer.
Gastric function can be studied by evaluating gastric emptying 
(GE), gastric smooth muscle function, and gastric myoelectrical 
activity. GE can be assessed by scintigraphy or octanoic acid 
breath test. Gastric smooth muscle function can be studied by 
gastric manometry, and surface electrogastrography (EGG) can 
evaluate the gastric myoelectrical activity. We will also describe 
the oral glucose tolerance test (OGTT) that can be used to deter-
mine the presence of dumping syndrome.
Ge—Gastric emptying Scintigraphy (GeS)
Gastric emptying scintigraphy is an objective physiologic non-
invasive test that provides a quantitative measurement of the GE. 
Even though it represents a standard method to measure GE, GES 
has several limitations such as the standardization of the meals 
used and the duration of the imaging. In 2008, the Society of 
Nuclear Medicine, American Gastroenterological Association, 
and Neurogastroenterology and Motility Society (16) described 
in a consensus statement the standardized measurement of GE 
in adults, mainly based on the work of Tougas et al. (17). In this 
study, the recommended low-fat meal consists of white bread, 
egg-white, jam, and water, and they recommend that the images 
be taken at 0, 1, 2, and 4  h after its ingestion. In 2015, Wong 
et al. (18) retrospectively examined this protocol in a pediatric 
population. They documented the difficulty for some children 
to finish the standard meal and the importance of documenting 
anthropometric factors (lower weight, height, and body surface 
area) and age which could influence the results of the GES.
Jolley et al. (19) were the first to investigate GE in 25 children 
with repaired OA–TOF. Only 20 of the 25 had GES. The aim of 
the study was not only to evaluate GE but also to see whether 
there was an association between GORD diagnosed via pH 
monitoring and gastroesophageal scintiscan and delay GE docu-
mented in GES. GE was slower in OA–TOF patients who had 
documented GORD on gastroesophageal scintiscan (p < 0.005). 
The main limitation of this study is that they used a liquid meal 
to assess GE, and the analysis was limited to the GE at 30 min 
(17); also, no definition of delayed GE was given. Furthermore, 
gastroesophageal scintiscan is not recommended for routine 
evaluation of pediatric patients with suspected GORD (20). This 
study also showed that slow GE was present in a subset of patients 
with GORD, diagnosed via a reflux score which was determined 
by pH monitoring. However, a reflux score, rather than an acid 
reflux index, was correlated with GE. The only factor associated 
with higher incidence of significant GORD and slow GE was an 
excessive tension at the anastomotic site (p < 0.005), potentially 
due to a decrease of the intra-abdominal oesophageal length and 
alteration of the configuration of the gastroesophageal junction.
In addition to this study, for the first time, Montgomery 
et al. evaluated 11 OA–TOF patients (age 5–10 years, median 
7.5 years) and 10 healthy controls with a GE using a solid meal 
and a symptom questionnaire (21). All the GE parameters 
measured, such as the half-emptying time, lag phase (time-
point when 90% of the marker remained in the stomach), and 
corrected half-emptying time (half-emptying time minus the 
lag phase), were significantly prolonged in OA–TOF patients 
when compared to controls. Also, in OA–TOF patients, the 
retention values at 60 and 90 min were increased and the emp-
tying rates (percentage of emptying per hour) were reduced in 
OA–TOF patients. Twenty-seven percent of OA–TOF children 
(3 over 11) had a delayed GE (e.g., retention values at 60 and 
90 min above 2 SDs). Regarding their clinical findings, there 
was no statistical difference in the GE studies in patients 
with or without symptoms (abdominal complaints and reflux 
symptoms).
In summary, although GES can be used to assess GE, here 
is, however, a dearth of data on normal values in children due 
to its low but non-negligible radiation risk. There is also a 
lack of standardization of the type (liquid vs. solid and caloric 
content) of meals used and the duration of the study. None of 
the studies mentioned above on OA–TOF patients followed 
the protocol recommended by Abell et  al. (16) and Tougas 
et al. (17).
Ge—13 C Octanoic Acid Breath Test (OBT)
Due to the drawbacks associated with the scintigraphy methods 
(mentioned previously), alternative techniques of assessing GE 
have been recently developed. 13C octanoic acid breath test OBT 
is a radiation-free method used to determine the GE rate of solid 
(22) and liquid meals in children or adults. This test assumes a 
normal absorption of the octanoic acid in the small bowel and 
normal lung function to determine the ratio of 13CO2/12CO2 in 
exhaled breath. Three mains parameters are calculated: the GE 
half-time (GE t1/2), the lag phase (T lag), and the gastric empty-
ing coefficient (GEC). Most of the studies have found a significant 
linear correlation with GE as determined by scintigraphy with 
respect to the GE half-time time and the lag phase (22–25). The 
GEC is specific for OBT.
Van Wijk et al. (26) were the first to combine multichannel 
intraluminal impedance–pH monitoring as a measure of GORD, 
oesophageal manometry as a measure of oesophageal motility 
and function, and GE via OBT as a measure of GE to evaluate the 
mechanisms underlying GORD in this cohort. They recruited 10 
children and 10 adults with OA–TOF. Among them, seven infants 
and nine adult patients were assessed by an OBT with a liquid and 
solid meal, respectively. Delayed GE (>90th percentile of age-, 
meal-, and sex-appropriate normal values) was found in 57.1% of 
infants (four infants over seven) and 22.2% of adults (two adults 
over nine). When GE half-life was compared to oesophageal motil-
ity or bolus clearance, no associations were found (R = −0.48, 
p =  0.32 and R = −0.56, p =  0.23, respectively). However, the 
normal values used to assess the delayed GE were not available in 
the manuscript or referenced as published data. In addition, the 
choice of defining an abnormal GE half-life being above the 90th 
percentile may overrepresent the gastric dysfunction.
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Gastric Smooth Muscle Function—Gastric 
Manometry
Conventional manometry and more recently high-resolution 
manometry have added a new method to assess gastric motility 
(27, 28). Conventional gastric manometry is not a commonly 
used method to study gastric motility, and high-resolution 
manometry needs further investigation to understand its role 
and compare its finding with other clinical tests. There has been 
only one study so far which used conventional manometry to 
study gastric function in OA–TOF patients. Eleven OA–TOF 
patients, aged from 13 to 23 years, were recruited by Romeo et al. 
to evaluate their gastric function via GES and gastric manometry 
(29). Like Montgomery et al., they used a solid meal to assess the 
GE, in contrast to Jolley et al. who chose a liquid meal. Delayed 
GE was defined as a t½ more than 90 min and was seen in 36% 
of the patients (4 over 11). Two of them were symptomatic of 
GORD, and two remaining patients were asymptomatic. All four 
presented with altered gastric motility at manometry. Also, 45% 
of patients demonstrated abnormal gastric peristaltic activity and 
antral hypo motility on manometric testing. This involved an 
increased duration of the third phase of the interdigestive cycle, 
reduction of the frequency and reduction of the amplitude of the 
peristaltic waves. However, like the previous studies, there was 
poor correlation between manometry results and symptoms, and 
abnormal gastric motility was also seen in 20% of asymptomatic 
patients. This work was the first to study gastric function in adult 
OA–TOF patients and showed that although gastric motility 
disorder can still be present in adulthood, it may not always be 
responsible for the GI symptoms. The authors felt that evaluation 
of gastric function may be useful in dyspeptic older OA–TOF 
patients.
Myoelectrical Activity—eGG
Electrogastrography is a non-invasive method for the meas-
urement of gastric myoelectrical activity using cutaneous 
electrodes (30). There is increasing evidence of its validity since 
the 1990s. EGG chiefly provides information on myoelectrical 
rhythm and amplitude/power of the stomach. If the recording 
of the electrogastrogram follows an adequate preparation of the 
skin and electrode placement, it is an accurate measurement of 
gastric slow waves (31). There are currently no recommenda-
tions regarding a standard meal for EGG. However, the meal 
composition is important as solid, liquid, or containing a high 
percentage of fat may result in different postprandial EGG 
responses (32, 33). Established EGG parameters are derived 
from the spectral analysis, and used to classify the result of the 
EGG. The parameters looked at include dominant frequency 
(frequency appearing with peak power value of spectra), domi-
nant power (the power observed at the dominant frequency), 
power ratio (ratio between the power in the postprandial period 
to the fasting period), percentage of normal gastric slow waves 
[the frequency of normal slow waves is between 2 and 4 cycles 
per minute (cpm)]. The EGG is described as bradygastria if the 
dominant frequency is less than 2 cpm and tachygastria if it is 
higher than 4 cpm and less than 9 cpm. Arrhythmia is defined 
if no dominant power is documented. Finally, bradygastria, 
tachygastria, or arrhythmia defines the presence of dysrhythmia. 
Although dysrhythmia can be found in healthy controls, nor-
mogastria (slow waves between 2 and 4 cpm) should represent 
more the 70% in healthy controls (34). Several studies described 
a variation in their normative values, increasing the difficulty to 
compare them.
Cheng et al. (35) were among the first to assess children with 
OA–TOF via EGG. Their study looked at 18 OA–TOF patients 
and 10 healthy controls, with a mean age of 2.3 years (2 weeks to 
12 years) and 2.1 years (1 month to 10 years), respectively. First, 
the dominant frequency did not differ significantly between the 
two groups. Even though, the instability coefficient (SD divided 
by the mean value of frequency) is the best-established param-
eter to describe the variation of the regularity of the slow waves, 
the distribution of frequency was used in the study. OA–TOF 
patients had a significantly wider distribution of frequency than 
the controls. The authors postulated that this was secondary to 
either the gastric pacemaker cells not firing at a regular rhythm or 
due to abnormalities in intrinsic nerves which modulate smooth 
muscle cells resulting in poor electromechanical coupling and 
abnormal gastric contraction. Interestingly, none of the four 
patients with abnormal EGG (two patients with bradygastria and 
the two patients with tachygastria) were symptomatic. However, 
no validated questionnaire was used to determine the presence or 
absence of reflux symptoms.
Yagi et al. (36) evaluated the gastric function using EGG in 13 
OA–TOF children, aged from 1 to 17 years old (mean 7.6 years), 
and compared them with five controls. EEG anomalies were only 
reported in OA–TOF, and they were present in 38% of them (5 
over 13). Yagi et al. defined dysrhythmia when the SD of peak 
spectral frequencies was larger than 1.3. Even though this defini-
tion varies in the literature, it is significant that only OA–TOF 
patients (38.4%) in this study had dysrhythmia (two only in the 
postprandial period and three in the fasting and postprandial 
period). In addition, the power ratio of the controls was sig-
nificantly higher than that of the OA–TOF patients (7.6 ±  9.0 
vs. 2.6 ±  1.7, p <  0.05). The power ratio was also significantly 
lower in OA–TOF patients with dysrhythmia compared to 
those without and significantly lower even in OA–TOF patients 
without dysrhythmia compared to controls, which is suggestive 
of impaired gastric contractility in these patients. However, there 
was no statistical difference between the power ratio of OA–TOF 
patients with and without dysrhythmia. OA–TOF patients 
with dysrhythmias also had significantly higher mean spectral 
frequencies than patients without dysrhythmias in both fasting 
and postprandial states (p < 0.05). There were no differences in 
mean spectral frequencies between OA–TOF patients without 
dysrhythmia and controls, unlike the power ratio. However, 
currently, there is no data in the literature that describes the role 
of mean spectral frequencies in an EGG study. Most studies use 
the parameters described above. All five dysrhythmic patients 
were asymptomatic. A contrast study, which is neither specific 
nor sensitive for the diagnosis of GORD, was used to evaluate 
reflux in this study. Contrast study showed GORD in 3/5 (60%) 
of the dysrhythmic patients. The authors postulated that the 
dysrhythmia detected in the OA–TOF patients might be due to 
deficiency of intrinsic inhibitory innervation or a lack of extrinsic 
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autonomic inhibition, a theory supported by prior research by 
Nakazato et al. and Qi et al.
Gastric myoelectrical activity and gastroesophageal disease 
were also studied in infants with OA–TOF by Bokay et al. (37). 
Fifteen OA–TOF infants (mean age of 84 days) and 10 controls 
were investigated via EGG and 24 h oesophageal pH monitor-
ing for the OA–TOF infants. A total of 73.3% of the OA–TOF 
patients had an abnormal pattern when compared to the controls 
(10%) during the fasting period. The authors used a cutoff of 
less than 60% of their percentage of normal slow waves (2–4 
cpm) to define an abnormal EGG. In the postprandial phase, a 
significant increase in bradygastria and a decrease in tachycardia 
were observed in the OA–TOF cohort. No significant difference 
was found in the dominant power between the two groups, either 
before or after the meal. The authors postulated the dysrhythmia 
seen was due to the abnormalities in Auerbach plexus, leading 
to poor propagation of electrical potential which in turn results 
in uncoordinated smooth muscle contraction and peristalsis. 
They felt that the abnormal gastric electrical activity, during the 
fasting and/or postprandial period, may lead to uncoordinated 
contraction of the stomach. Among the 15 OA–TOF patients, 9 
had pathological 24  h oesophageal pH monitoring values, and 
6 had clinical reflux based on symptoms. When comparing the 
patients with or without GORD, there were no differences in the 
distribution of myoelectrical waves or the dominant power, either 
at rest or after the meal. No information regarding the power ratio 
was available in this study, making it difficult to compare these 
results with Yagi et al.’s study. Bokay et al. concluded that EGG 
is a useful non-invasive investigation to document disturbed 
neuromuscular function, even in infants, and further studies are 
required to understand the pathophysiology of feeding distur-
bances in this population.
To summarize, although EGG is an easy to perform, non-
invasive tool to investigate myoelectrical activity, the lack of 
standardization of the EGG parameters described in the various 
studies, makes it is difficult to compare the studies. Also, in the 
literature, the test meal is poorly described. The different test 
meals in these three studies reflect this statement.
Dumping Syndrome—OGTT
Dumping Syndrome is thought to occur when a rapid transit of 
gastric contents reaches the small bowel; resulting in an early 
postprandial hyperglycemia, which then, leads to a profound 
insulin response producing a secondary late hypoglycemia. The 
symptoms can be non-specific and can present with malaise, 
lethargy, nausea, retching, failure to thrive, diaphoresis, tachy-
cardia, and watery diarrhea. The gold standard for the diagnosis 
of dumping syndrome is OGTT. Serial blood sugar measure-
ments are done during a 4-h period following a sugar load 
(1.75 g/kg, maximum 75 g) to detect early hyperglycemia or late 
hypoglycemia. The treatment of dumping syndrome is mainly 
by dietary modification by avoiding simple carbohydrates, sup-
plementation with complex carbohydrates (corn starch, pectin), 
continuous gastric or transpyloric feeds. Some studies have also 
reported a benefit with Acarbose (38). Rarely octreotide, diazox-
ide, prednisolone, or even TPN is needed in severe cases. The 
increased risk of dumping syndrome in adults after oesophageal, 
gastric, or bariatric surgery is well established (39). Most the 
studies focus on post-fundoplication (antireflux surgery) 
dumping syndrome (40). Holschneider et al. (41) investigated 
the complications following fundoplication in children with 
a focus on OA–TOF. The incidence of postoperative dumping 
syndrome has been reported to be significantly higher (18.3%) 
in the OA–TOF cohort when compared to children without OA–
TOF (1.6%). Michaud et al. (42) were the first group to report 
two cases of symptomatic OA–TOF children without previous 
fundoplication or associated microgastria who presented with 
dumping syndrome diagnosed with OGTT. They suggested that 
dumping syndrome should be considered in OA–TOF children 
who present with non-specific gastrointestinal symptoms that 
cannot be explained otherwise (e.g., anastomotic stenosis, gas-
troesophageal reflux, oesophageal dysmotility, etc.). Large mul-
ticentre prospective studies are required to determine the true 
incidence of dumping syndrome in OA–TOF patients. Although 
OGTT is the gold standard for the diagnosis of dumping syn-
drome, the role of complementary GES (showing accelerated 
GE) remains yet to be determined. In addition, normative values 
for OGTT have also not been firmly established, especially for 
all ages for the diagnosis of dumping syndrome. Given these 
findings, it is important that clinicians consider dumping syn-
drome in every child treated surgically for oesophageal atresia 
presenting with digestive symptoms, malaise, failure to thrive, 
or refusal to eat. Dumping syndrome is often underdiagnosed 
in this cohort because of the non-specific clinical symptoms and 
because the GI symptoms are often thought to be due to other 
more commonly occurring factors, such as strictures, GORD, 
and dysmotility.
Symptoms Questionnaires
Gastroesophageal reflux is often diagnosed based on non-
specific symptoms, which is not ideal especially for the younger 
child. The NASPGHAN-ESPGHAN guideline for the diagnosis 
and treatment of GORD in children states that in infants and 
toddlers, there is no symptom or symptom complex that is 
diagnostic of GORD or predicts response to therapy (20). This 
is especially so in the OA–TOF patient in whom symptoms 
secondary to eosinophilic oesophagitis, anastomotic stricture, 
and dysmotility could mimic reflux disease. There is also a 
dearth of validated questionnaires to evaluate GORD in all age 
groups and to evaluate and diagnose abnormal gastric function 
vs. GORD. Hence, it is not surprising that none of the studies 
mentioned above which evaluated gastric function and its corre-
lation with gastrointestinal symptoms used a validated symptom 
questionnaire.
Although the PedsQL currently has subsections which relate 
to gastric dysfunction, further studies are needed to establish 
more specific validated questionnaire for children and their 
parents regarding the symptoms related to gastric dysfunction. 
Significantly, none of the studies on GE, myoelectrical activ-
ity, and motility found a significant correlation between the 
abnormalities in gastric function and symptoms. This lack of 
correlation might well be due to not only the small sample sizes 
but also the lack of a validated symptom questionnaire for gastric 
function.
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TReATMeNT OF ABNORMALiTieS  
iN GASTRiC FUNCTiON
Role of Prokinetic
The studies investigating the use of prokinetic in OA–TOF 
patients are scarce. Most of them evaluate the benefits of pro-
kinetics in OA–TOF patients with oesophageal dysmotility or 
GORD. No study so far has specifically looked at the role of a 
prokinetic on gastric function in OA–TOF patients. Ideally, the 
effectiveness of the prokinetic drug should be evaluated not 
only on pathophysiologic changes in EGG and GE but also on 
patient-related outcomes with validated symptom question-
naires. Prokinetic drugs can improve gastric motor function/
emptying by accelerating rate of GE, and by their effect on gastric 
peristalsis.
Cisapride increases the motility of the upper gastrointestinal 
tract by acting directly as a serotonin 5-HT4 agonist and indirectly 
as a parasympathomimetic. Its action on the serotonin receptors 
increases the release of acetylcholine in the enteric nervous 
system, improving the GE. Tegaserod has a similar mechanism 
by being a 5-HT4 receptor agonist. However, both cisapride and 
tegaserod presented significant side effects, mainly cardiac, lead-
ing to a withdrawl of their use (43, 44).
Domperidone is a peripheral dopamine antagonist with affin-
ity for D2-receptors that increases motility and GE (45). It works 
by antagonizing the effects of dopamine on the gastrointestinal 
tract, but has no cholinergic activity. It does this by inhibiting 
fundal relaxation, and by increasing amplitude and peristalsis of 
the gastric antrum and duodenum. Studies show mixed results 
regarding symptomatic improvements. Its efficacy was mainly 
investigated in diabetes gastroparesis, with reduction in nausea 
and vomiting. However, the trials were small and had meth-
odological limitations (46). Domperidone has been shown to 
improve gastric dysrhythmia in diabetic gastroparesis (47, 48). 
Three aspects should be considered when prescribing domperi-
done. First, it has the propensity to increase the QT interval on 
electrocardiogram, potentially leading to arrhythmia. Therefore, 
baseline and follow-up electrocardiogram are recommended, 
and Domperidone should be discontinued in case of age-related 
prolonged corrected QT interval (49). Second, domperidone 
increases prolactin and can result in mild lactation. Third, it alters 
the function of the cytochrome P450 2D6, theoretically increas-
ing the risk of drug interaction.
Erythromycin, in a sub-antimicrobial dose, has been used 
in gastroparesis. It mimics the effect of motilin in the proximal 
gastrointestinal tract, provoking migrating motor complexes 
and contractions in the antrum and duodenum via cholinergic 
actions (50, 51). Several studies have documented an accelerated 
GE both in healthy controls and with patients with gastroparesis 
(52, 53). However, the results were not consistent with some 
studies showing a poor response (54). Erythromycin also leads to 
downregulation of the motilin receptor, inducing a tachyphylaxis. 
Some studies documented a drop of the response after 4 weeks 
of treatment (55). As with domperidone, erythromycin interacts 
with other drugs metabolized by the cytochrome P450 3A4. Like 
Domperidone, it can also be associated with the development 
of prolonged corrected QT interval, which necessitates close 
monitoring during its use.
Role of Gastric Pacing
Gastric pacing, or gastric electrical stimulation, is a surgical 
treatment option. It has been evaluated in patients with refractory 
gastroparesis (56). After the placement of the electrodes into the 
muscle layer of the stomach, several modalities of stimulation are 
available, of which, high-frequency/low-energy stimulation with 
short pulse stimulation is the one most often described. There 
are currently no studies that have evaluated the effect of gastric 
pacing in the OA–TOF cohort. However, there might potentially 
be a role for gastric pacing in OA–TOF patients with significant 
feeding difficulties and vomiting not responding to conventional 
therapy who have documented abnormalities in GE and myoe-
lectrical activity.
CONCLUSiON
Due to the substantial reduction of mortality in patients with 
oesophageal atresia and TOF, the aim of clinicians looking after 
OA–TOF patients has shifted to improvements of patient-related 
outcomes and reduction of the morbidity of gastrointestinal 
disease affecting them. In the past, the literature has focused 
on GORD, oesophageal dysmotility, and feeding difficulties. 
However, the evidence that abnormalities in gastric function can 
contribute to symptoms such as vomiting, dyspepsia, and feeding 
difficulties is increasing. This review provides an overview of the 
pathophysiology of abnormal gastric function in this cohort, and 
the armamentarium of investigations available to gastroenterolo-
gists to diagnose abnormal gastric function. The standardization 
of the methods, especially the test meals and the establishment of 
rigorous standards, are mandatory to determine normal values 
for GE and EGG in children.
Even with limited literature currently available on this topic, 
this review highlights the importance of being aware of the risk of 
gastric dysfunction in oesophageal atresia and TOF patients. We 
have described the investigation of gastric function with objective 
tests, such as GES or OBT to evaluate GE, EGG to evaluate gastric 
myoelectrical activity, and OGTT to exclude dumping syndrome. 
Potential treatment modalities for these abnormalities in gastric 
function have also been described.
Although most of the studies described had small cohorts, 
they all showed abnormalities in GE and myoelectrical activity 
in a significant proportion of OA–TOF patients. However, none 
of the studies could conclusively show a significant correlation 
between the abnormalities in gastric function and symptoms, 
although that might well have been due to small sample sizes and 
lack of a specific validated symptom questionnaire.
FUTURe DiReCTiONS
Several countries have launched a national plan for rare diseases, 
thus, increasing the awareness of conditions, such as OA–TOF, 
such as NORD in the United States, or EURORDIS in Europe. 
Recently, members of the European and North American 
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Society of Pediatric Gastroenterology, Hepatology and Nutrition 
developed uniform consensus guidelines for the management of 
gastrointestinal complications in children with OA–TOF (3). 
This illustrates the need for collaborations in the field of rare 
diseases. To improve our understanding of gastric function 
in OA–TOF, multicentre collaborative prospective trials are 
needed. Only such large multicentre studies will help determine 
whether treating abnormalities in GE and myoelectrical activity 
improves GORD, dyspepsia and feeding difficulties in OA–TOF 
patients.
Patient-related outcome instruments, including the develop-
ment of validated patient symptom, and parent-proxy question-
naires are essential in the development of treatment modalities, 
assuring therapeutics benefits to the patients.
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